361 related articles for article (PubMed ID: 36675817)
1. Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer.
Shum HCE; Wu K; Vadgama J; Wu Y
J Pers Med; 2023 Jan; 13(1):. PubMed ID: 36675817
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming in type 2 diabetes and the development of breast cancer.
Martin SD; McGee SL
J Endocrinol; 2018 May; 237(2):R35-R46. PubMed ID: 29487204
[TBL] [Abstract][Full Text] [Related]
3. Tumor metabolic reprogramming in lung cancer progression.
Li X; Liu M; Liu H; Chen J
Oncol Lett; 2022 Aug; 24(2):287. PubMed ID: 35814833
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
5. [Metabolic reprogramming in cancer: the art of balance].
Yi M; Xiang B; Li X; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 38(11):1177-87. PubMed ID: 24316928
[TBL] [Abstract][Full Text] [Related]
6. Amino acid metabolic reprogramming in tumor metastatic colonization.
Wang Z; Wu X; Chen HN; Wang K
Front Oncol; 2023; 13():1123192. PubMed ID: 36998464
[TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review.
Liu Y; Zhang Z; Wang J; Chen C; Tang X; Zhu J; Liu J
Onco Targets Ther; 2019; 12():1195-1204. PubMed ID: 30863087
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and immunity in breast cancer.
Zhang D; Xu X; Ye Q
Front Med; 2021 Apr; 15(2):178-207. PubMed ID: 33074528
[TBL] [Abstract][Full Text] [Related]
9. [Lipid Metabolic Reprogramming and Metabolic Stress in Liver Cancer].
Xu Z; Yuan KF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):561-565. PubMed ID: 34323031
[TBL] [Abstract][Full Text] [Related]
10. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
Zhang M; Wei T; Zhang X; Guo D
Front Immunol; 2022; 13():937406. PubMed ID: 36131916
[TBL] [Abstract][Full Text] [Related]
11. Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance.
Lei P; Wang W; Sheldon M; Sun Y; Yao F; Ma L
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444501
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
Li Z; Sun C; Qin Z
Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
[TBL] [Abstract][Full Text] [Related]
13. Relationship between metabolic reprogramming and drug resistance in breast cancer.
Lv L; Yang S; Zhu Y; Zhai X; Li S; Tao X; Dong D
Front Oncol; 2022; 12():942064. PubMed ID: 36059650
[TBL] [Abstract][Full Text] [Related]
14. Perspectives of Reprogramming Breast Cancer Metabolism.
Wang YP; Lei QY
Adv Exp Med Biol; 2017; 1026():217-232. PubMed ID: 29282686
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
Tyszka-Czochara M; Konieczny P; Majka M
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
[TBL] [Abstract][Full Text] [Related]
16. A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes-Associated Breast Cancer.
Hao Q; Huang Z; Li Q; Liu D; Wang P; Wang K; Li J; Cao W; Deng W; Wu K; Su R; Liu Z; Vadgama J; Wu Y
Adv Sci (Weinh); 2022 Feb; 9(6):e2102303. PubMed ID: 35023320
[TBL] [Abstract][Full Text] [Related]
17. Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer.
Huang P; Fan X; Yu H; Zhang K; Li H; Wang Y; Xue F
J Transl Med; 2023 Feb; 21(1):94. PubMed ID: 36750868
[TBL] [Abstract][Full Text] [Related]
18. Intracellular metabolic reprogramming mediated by micro-RNAs in differentiating and proliferating cells under non-diseased conditions.
Singh V
Mol Biol Rep; 2021 Dec; 48(12):8123-8140. PubMed ID: 34643930
[TBL] [Abstract][Full Text] [Related]
19. The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer?
Moulder DE; Hatoum D; Tay E; Lin Y; McGowan EM
Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29890631
[TBL] [Abstract][Full Text] [Related]
20. Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment.
Shunxi W; Xiaoxue Y; Guanbin S; Li Y; Junyu J; Wanqian L
Adv Nutr; 2023 Sep; 14(5):1050-1066. PubMed ID: 37187454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
